These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns. Koga N Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391 [TBL] [Abstract][Full Text] [Related]
5. Anion-blood contact reaction (ABC reaction) in patients treated by LDL apheresis with dextran sulfate-cellulose column while receiving ACE inhibitors. Agishi T JAMA; 1994 Jan; 271(3):195-6. PubMed ID: 7695665 [No Abstract] [Full Text] [Related]
6. LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors. Keller C; Grützmacher P; Bahr F; Schwarzbeck A; Kroon AA; Kiral A Lancet; 1993 Jan; 341(8836):60-1. PubMed ID: 8093314 [No Abstract] [Full Text] [Related]
7. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits. Yamamoto T; Yamashita T Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785 [TBL] [Abstract][Full Text] [Related]
8. [Kinetics of lipids and lipoproteins with determination of the recovery rate in the non-steady state following plasma, membrane filtration and dextran sulfate adsorption apheresis in hypercholesterolemia]. Schwartzkopff W; Gräfenhahn H; Nold A; von Baeyer H; Bimmermann A; Schleicher J Biomed Tech (Berl); 1989 Oct; 34(10):232-42. PubMed ID: 2479419 [TBL] [Abstract][Full Text] [Related]
10. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia. Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773 [No Abstract] [Full Text] [Related]
11. What's going on in LDL apheresis. Onofrillo D; Accorsi P Transfus Apher Sci; 2007 Dec; 37(3):213-21. PubMed ID: 18054286 [No Abstract] [Full Text] [Related]
12. [LDL cholesterol apheresis by adsorption to dextran sulfate]. Grunewald RW; Ditschuneit HH; Klein J; König W; Grunewald JM; Franz HE Infusionsther Transfusionsmed; 1992 Aug; 19(4):194-6. PubMed ID: 1422078 [TBL] [Abstract][Full Text] [Related]
13. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric. Adamski J; Jamensky L; Ross J; Siegel DL; Sachais BS J Clin Apher; 2010; 25(6):354-7. PubMed ID: 20806416 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy. Gordon BR; Saal SD J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816 [TBL] [Abstract][Full Text] [Related]
15. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques. Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309 [TBL] [Abstract][Full Text] [Related]
16. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis. Bosch T Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411 [TBL] [Abstract][Full Text] [Related]
17. Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies. Schechner V; Ben-Ami R; Hershcovici T; Yedgar S; Beigel Y; Shapira I; Berliner S; Barsthein G Ther Apher Dial; 2005 Oct; 9(5):379-84. PubMed ID: 16202011 [TBL] [Abstract][Full Text] [Related]